Quest Diagnostics Incorporated DGX

NYSE · Healthcare · Medical - Diagnostics & Research

$258.28

Close on Fri, 20 Nov 2026 · market value $28.4B

What the price is betting on

Below its record

At $258, the price assumes revenue grows about 1.9% a year for five years, from $11.8B to about $12.8B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.

The price assumes1.9%
Analysts, next two years4.9%
Last 3 years9.4%

Revenue growth a year. The price figure comes from a reverse DCF at a 7.5% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than DGX? Check up to 5 of your stocks at once, free, no account.

0$5B$10B$15B$11.8B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$275

Base

$309

Bull

$347

Today $258

  • Bear $275. Cash flow grows 3% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $309. Cash flow grows 5% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $347. Cash flow grows 7% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$11.9B$12.1B, on the path
  3. FY2027$12.1B$12.6B, on the path
  4. FY2028$12.4B$13.2B, on the path
  5. FY2029$12.6B$13.9B, on the path
  6. FY2030$12.8B$11.6B, below the path

Each year's revenue at 1.9% growth from $11.8B in the 12 months to September 2026.

At a glance

Healthcare · Medical - Diagnostics & Research · listed on NYSE

Revenue, FY2025
$11B
Growth, 3 years a year
9.4%
Cash margin
12%
Net debt
$6.5B
Shares, 3-year change
−4.2%
Dividend yield
1.2%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.